Results of the ReCH-MIE 2024 call for proposals

Call for proposals for hospital-based clinical research projects dedicated to emerging and re-emerging infectious diseases

Last updated on 22 September 2025

Main points

  • The Directorate General for Healthcare Provision (DGOS) of the French Ministry of Health has published the list of projects selected for the ReCH-MIE 2024 call for proposals.
  • Launched in close partnership with ANRS MIE, which is responsible for scientific coordination, this program is funded by the DGOS.

The ReCH-MIE call for proposals: hospital clinical research projects dedicated to emerging and re-emerging infectious diseases

The call for proposals, now in its fourth edition, is enjoying growing success. Its aim is to support applied clinical research projects in hospitals focusing on emerging and re-emerging infectious diseases, including multi-resistant bacteria and fungi.

It is part of a global strategy led by ANRS MIE and contributes to the agency’s funding for emerging infectious diseases.

The nine project laureates were selected from among 21 projects received at the end of the scientific evaluation process, conducted by an independent committee of experts led by ANRS MIE, for total funding of more than €5.4 million.

Scientific themes of ReCH-MIE 2024

These projects cover a wide range of priority themes:

  • Emerging viral infections, with metatranscriptomic or vaccine approaches
  • Advanced diagnostic methods applied to vulnerable populations such as transplant recipients or immunocompromised individuals
  • Innovative treatment approaches, including strategies for optimizing antibiotic or antiviral treatments

Discover the 9 laureates of the ReCH-MIE 2024

ANRS MIE would like to warmly thank all the teams that submitted applications, as well as the experts involved in this process.

Project leader
Fund management institution
Name of the project
Title of the project
Budget

LERUEZ VILLE Marianne

ASSISTANCE PUBLIQUE-HÔPITAUX DE PARIS

MetaMFIU

Exploration étiologique des morts foetales in utero par métatranscriptomique NGS

418 923,23 €

SALMONA Maud

ASSISTANCE PUBLIQUE-HÔPITAUX DE PARIS

METARESP

Diagnostic métagénomique rapide des infections respiratoires chez les receveurs de greffes de cellules souches hématopoïétiques

299 929,00 €

BARRAUD Olivier

CHU DE LIMOGES

INVICTUS

INVICTUS INtérêt de la Valeur prédictive négative des Intégrons dans la réduCtion de la consommation d’anTibiotiques à large spectre pour le traitement des infections Urinaires aux urgenceS : étude randomisée

632 550,00 €

SURGERS Laure

ASSISTANCE PUBLIQUE-HÔPITAUX DE PARIS

TEMtoGo

Efficacité de la témocilline comparée à la prise en charge standard dans le traitement des infections à Neisseria gonorrhoeae : essai randomisé multicentrique contrôlé de non infériorité

695 268,47 €

BASTARD Paul

ASSISTANCE PUBLIQUE-HÔPITAUX DE PARIS

SIRIUS

Caractérisation des infections pédiatriques sévères à virus respiratoire syncytial à l’ère de la prophylaxie antivirale

496 028,56 €

CONRAD Anne

HOSPICES CIVILS DE LYON

RSVaxID

Immunogénicité et sécurité d’emploi de deux stratégies vaccinales contre le virus respiratoire syncytial chez des transplantés pulmonaires et des receveurs d’allogreffe de cellules souches hématopoïétiques : un essai phase II

1 300 002,00 €

COURJON Johan

CHU DE NICE

ROADMAP

Plateforme adaptative internationale d’essai clinique randomisé multidomaines pour les infection de prothèse articulaire

555 679,00 €

PEUCHANT Olivia

CHU DE BORDEAUX

SHORT-LGV

Etude multicentrique évaluent l’efficacité de 7 jours de doxycycline pour le traitement de lymphogranulomatose vénérienne anale asymptomatique.

351 669,00 €

RICHIER Quentin

ASSISTANCE PUBLIQUE-HÔPITAUX DE PARIS

R-IPerCoV

Evaluation de la performance diagnostique de l’infection par le SARS-CoV-2 d’un prélèvement d’air expiré par technique R-tube chez les patients immunodéprimés en comparaison au lavage broncho-alvéolaire

231 727,78 €

2025 edition

ANRS MIE is continuing its commitment to DGOS as part of this call for proposals.
The 2025 edition of RechMIE will be launched in September 2025.

2025 call for proposals